![Mark Versavel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Mark Versavel is the founder of Vzenium LLC.
He previously worked as the Chief Medical Officer at Cavion, Inc., Alzheon, Inc., and NeuroBo Pharmaceuticals, Inc. In 2023, he held the position of Chief Medical Officer at Eliem Therapeutics, Inc. Dr. Versavel obtained an MBA from the University of Michigan in 2003.
He also earned a doctorate degree from Humboldt-Universität zu Berlin in 2003 and another doctorate degree from the University of Antwerp in 1983.
Cargos activos de Mark Versavel
| Empresas | Cargo | Inicio |
|---|---|---|
Vzenium LLC | Fundador | - |
Antiguos cargos conocidos de Mark Versavel.
| Empresas | Cargo | Fin |
|---|---|---|
| CLIMB BIO, INC. | Director Técnico/Científico/I+D | 01/10/2023 |
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Director Técnico/Científico/I+D | - |
| METAVIA INC. | Director Técnico/Científico/I+D | - |
| ALZHEON, INC. | Director Técnico/Científico/I+D | - |
Formación de Mark Versavel.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
97
Relaciones de 1er grado
8
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humboldt-Universität zu Berlin
 Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Antwerp
 University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
NeuroBo Pharmaceuticals, Inc.
 NeuroBo Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops disease-modifying therapies for neurodegenerative diseases | Health Technology |
Vzenium LLC |
- Bolsa de valores
- Insiders
- Mark Versavel
